Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Transient serotonin syndrome by concurrent use of electroconvulsive therapy and selective serotonin reuptake inhibitor: a case report and review of the literature.

Okamoto N, Sakamoto K, Yamada M.

Case Rep Psychiatry. 2012;2012:215214. doi: 10.1155/2012/215214. Epub 2012 Nov 20.

2.

Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy.

Korda JB, Pfaus JG, Kellner CH, Goldstein I.

J Sex Med. 2009 Oct;6(10):2901-9. doi: 10.1111/j.1743-6109.2009.01421.x. Epub 2009 Aug 11.

PMID:
19686432
3.

[Perstimulus asystole during electroconvulsive therapy: Clinical case and critical literature review].

Roche NC, Raynaud L, Bompaire F, Lucas JJ, Auxéméry Y.

Encephale. 2016 Feb;42(1):59-66. doi: 10.1016/j.encep.2015.06.004. Epub 2015 Sep 6. French.

PMID:
26350554
4.

Catatonic features in major depression relieved by electroconvulsive treatment: parallel evaluation of the status of platelet serotonin transporter.

Cupello A, Bandini F, Albano C, Favale E, Marchese R, Scarrone S, Trompetto C.

Int J Neurosci. 2008 Oct;118(10):1460-6. doi: 10.1080/00207450701870303.

PMID:
18788029
5.

Electroconvulsive Therapy Induces Transient Sensitivity for a Serotonin Syndrome: A Case Report.

Deuschle M, Böhringer A, Meyer-Lindenberg A, Sartorius A.

Pharmacopsychiatry. 2017 Jan;50(1):41-42. doi: 10.1055/s-0042-111519. Epub 2016 Jul 26.

PMID:
27458743
6.

Serotonin syndrome after electroconvulsive therapy in a patient on trazodone, bupropion, and quetiapine: a case report.

Cheng YC, Liang CM, Liu HC.

Clin Neuropharmacol. 2015 May-Jun;38(3):112-3. doi: 10.1097/WNF.0000000000000076.

PMID:
25970280
7.

Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.

Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, Afzali MH.

Psychiatry Res. 2014 Feb 28;215(2):355-61. doi: 10.1016/j.psychres.2013.12.008. Epub 2013 Dec 13.

PMID:
24374115
8.

Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depression.

Stain-Malmgren R, Tham A, Aberg-Wistedt A.

J ECT. 1998 Mar;14(1):15-24.

PMID:
9661089
9.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

10.

Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.

Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R.

J ECT. 2012 Sep;28(3):157-61. doi: 10.1097/YCT.0b013e31824f8296.

11.

Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment.

Langer G, Karazman R, Neumark J, Saletu B, Schönbeck G, Grünberger J, Dittrich R, Petricek W, Hoffmann P, Linzmayer L, et al.

Neuropsychobiology. 1995;31(4):182-94.

PMID:
7659199
12.

Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.

Salehi I, Hosseini SM, Haghighi M, Jahangard L, Bajoghli H, Gerber M, Pühse U, Holsboer-Trachsler E, Brand S.

J Psychiatr Res. 2016 May;76:1-8. doi: 10.1016/j.jpsychires.2016.01.012. Epub 2016 Jan 25.

PMID:
26859236
13.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
14.

[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].

Vignau J, Karila L, Costisella O, Canva V.

Encephale. 2005 May-Jun;31(3):349-57. Review. French.

PMID:
16142050
15.

Electroconvulsive therapy vs. paroxetine in treatment-resistant depression -- a randomized study.

Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze-Mönking H.

Acta Psychiatr Scand. 1997 Nov;96(5):334-42.

PMID:
9395150
16.

Serotonin syndrome: case report and review of the literature.

Weiner AL, Tilden FF Jr, McKay CA Jr.

Conn Med. 1997 Nov;61(11):717-21.

PMID:
9419960
17.

Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.

Yoosefi A, Sepehri AS, Kargar M, Akhondzadeh S, Sadeghi M, Rafei A, Alimadadi A, Ghaeli P.

J ECT. 2014 Mar;30(1):15-21. doi: 10.1097/YCT.0b013e3182a4b4c6.

PMID:
24091902
18.

Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.

Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T.

Mol Psychiatry. 2007 Feb;12(2):167-89. Epub 2006 Oct 10.

PMID:
17033635
19.

Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1.

20.

Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study.

Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R, Lefkifker E.

Biol Psychiatry. 2000 Feb 15;47(4):314-24.

PMID:
10686266

Supplemental Content

Support Center